参考文献/References:
[1]Singer M,Deutschman CS,Seymour CW,et al.The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J].JAMA,2016,315(8):801-810.[2]ARDS Definition Task Force,Ranieri VM,Rubenfeld GD,et al.Acute respiratory distress syndrome:the Berlin Definition[J].JAMA,2012,307(23): 2526-2533. [3]Huppert LA,Matthay MA,Ware LB.Pathogenesis of Acute Respiratory Distress Syndrome[J]Semin Respir Crit Care Med,2019,40(1):31-39.[4]Bellani G,Laffey JG,Pham T,et al.Epidemiology,Patterns of Care,and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries[J].JAMA,2016,315(8):788-800.[5]Thompson BT,Chambers RC,Liu KD.Acute Respiratory Distress Syndrome[J].N Engl J Med,2017,377(6):562-572.[6]Joffre J,Hellman J,Ince C,et al.Endothelial Responses in Sepsis[J].Am J Respir Crit Care Med,2020,202(3):361-370.[7]陈加弟,龚迪,易玉虎,等.血管内皮糖萼在脓毒症急性肺损伤病理机制及诊断治疗中的作用[J].解放军医学杂志,2021,46(4):398-403.[8]Li J,Qi Z,Li D,et al.Alveolar epithelial glycocalyx shedding aggravates the epithelial barrier and disrupts epithelial tight junctions in acute respiratory distress syndrome[J].Biomed Pharmacother,2021,133:111026.[9]中国研究型医院学会休克与脓毒症专业委员会,中国人民解放军重症医学专业委员会,重症免疫研究协作组,等.脓毒症免疫抑制诊治专家共识[J].中华危重病急救医学,2020,32(11):1281-1289.[10]Cecconi M,Evans L,Levy M,et al.Sepsis and septic shock[J].Lancet,2018,392(10141):75-87.[11]蒋政宇,卞金俊,邓小明.免疫反应代谢调控:脓毒症研究的新方向[J].中华危重病急救医学,2019,31(1):122-125.[12]Deng Q,Zhao T,Pan B,et al.Protective Effect of Tubastatin A in CLP-Induced Lethal Sepsis[J].Inflammation,2018,41(6):2101-2109.[13]Kim SJ,Kim HM.Dynamic lipopolysaccharide transfer cascade to TLR4/MD2 complex via LBP and CD14[J].BMB Rep,2017,50(2):55-57.[14]Wu Y,Wang Y,Gong S,et al.Ruscogenin alleviates LPS-induced pulmonary endothelial cell apoptosis by suppressing TLR4 signaling[J].Biomed Pharmacother,2020,125:109868.[15]Reilly JP,Wang F,Jones TK,et al.Plasma angiopoietin-2 as a potential causal marker in sepsis-associated ARDS development:evidence from Mendelian randomization and mediation analysis[J].Intensive Care Med,2018,44(11):1849-1858.[16]宋振举.中国汉族人群急性肺损伤/急性呼吸窘迫综合征的遗传易感性研究[D].上海:复旦大学,2011.[17]Winkler MS,Nierhaus A,Poppe A,et al.Sphingosine-1-Phosphate:A Potential Biomarker and Therapeutic Target for Endothelial Dysfunction and Sepsis?[J].Shock,2017,47(6):666-672.[18]Zhao J,Tan Y,Wang L,et al.Serum sphingosine-1-phosphate levels and Sphingosine-1-Phosphate gene polymorphisms in acute respiratory distress syndrome:a multicenter prospective study[J].J Transl Med,2020,18(1):156. [19]刘洁泉,支绍册,洪广亮,等.急诊监护室脓毒症并发ARDS 患者的临床特点及预后因素分析[J].中华全科医学,2014,12(6):856-858,893. [20]Fan E,Brodie D,Slutsky AS.Acute Respiratory Distress Syndrome:Advances in Diagnosis and Treatment[J].JAMA,2018,319(7):698-710.[21]喻思涵,马宇腾,李旭.非肺源性脓毒症和肺部感染致急性呼吸窘迫综合征患者凝血指标差异及与预后的相关性[J].中华内科杂志,2021,60(7):650-655.[22]Luo L,Shaver CM,Zhao Z,et al.Clinical Predictors of Hospital Mortality Differ Between Direct and Indirect ARDS[J].Chest,2017,151(4):755-763.[23]宗晓龙,李真玉,魏殿军,等.肺泡表面活性蛋白D、血管性血友病因子及白介素8对脓毒症诱发急性呼吸窘迫综合征的预测和预后意义[J].临床检验杂志,2017,35(2):118-121.[24]Loghmani H,Conway EM.Exploring traditional and nontraditional roles for thrombomodulin[J].Blood,2018,132(2):148-158.[25]柴海霞,刘静梅,王会军,等.血清可溶性血栓调节蛋白及乳脂球表皮生长因子8水平与感染性休克合并急性肾损伤患者预后的相关性分析[J].中国医药,2022,17(3):425-428.[26]孙会志,孙海英,李亚平.脓毒症并发ARDS患者血清sTM、suPAR、Ang-2水平与炎症因子及预后的关系[J].检验医学与临床,2022,19(8):1075-1079.[27]Jiang Y,Luo Q,Han Q,et al.Sequential changes of serum KL-6 predict the progression of interstitial lung disease[J].J Thorac Dis,2018,10(8):4705-4714.[28]邱佳男,宋吉官,陈龙,等.KL-6和SP-D在脓毒症合并急性肺损伤患者中的表达及其与患者预后的关系[J].临床急诊杂志,2021,22(3):188-192.[29]Zhang R,Ge J.Proteinase-Activated Receptor-2 Modulates Ve-Cadherin Expression to Affect Human Vascular Endothelial Barrier Function[J].J Cell Biochem,2017,118(12):4587-4593.[30]Sauteur L,Affolter M,Belting HG.Distinct and redundant functions of Esama and VE-cadherin during vascular morphogenesis[J].Development,2017,144(8):1554-1565.[31]文军,张永军,陈群,等.脓毒症并发ARDS患者血清VE-Cad水平、Ang-2水平变化及其与预后的关系[J].河北医科大学学报,2021,42(4):376-379,385.[32]Pratte KA,Curtis JL,Kechris K,et al.Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD[J].Respir Res,2021,22(1):127.[33]Gryszczyńska B,Budzyń M,Formanowicz D,et al.Selected Atherosclerosis-Related Diseases May Differentially Affect the Relationship between Plasma Advanced Glycation End Products,Receptor sRAGE,and Uric Acid[J].J Clin Med,2020,9(5):1416.[34]Jones TK,Feng R,Kerchberger VE,et al.Plasma sRAGE Acts as a Genetically Regulated Causal Intermediate in Sepsis-associated Acute Respiratory Distress Syndrome[J].Am J Respir Crit Care Med,2020,201(1):47-56.[35]任娜,刘名胜,周森,等.血浆晚期糖基化终末产物和可溶性糖基化终末产物受体水平与脓毒症患者病情严重程度及预后的相关性[J].实用医学杂志,2021,37(21):2764-2769.[36]Zhao J,Tan Y,Wang L,et al.Discriminatory ability and prognostic evaluation of presepsin for sepsis-related acute respiratory distress syndrome[J].Sci Rep,2020,10(1):9114.[37]Li X,Shen H,Zhou T,et al.Does an increase in serum FGF21 level predict 28-day mortality of critical patients with sepsis and ARDS?[J].Respir Res,2021,22(1):182.[38]王慧娟,张春芳,王宜姗.血清血红素加氧酶-1水平与脓毒症继发急性呼吸窘迫综合征相关性研究[J].标记免疫分析与临床,2021,28(11):1832-1835.[39]张勤,胡相悦.血清KL-6、sTM、CC-16对脓毒症并发急性呼吸窘迫综合征患者预后的价值研究[J].临床急诊杂志,2020,21(9):711-716.[40]郑艳妮,沙海旺,姜文娟.E/Em联合血清可溶性血栓调节蛋白评估脓毒症并发急性呼吸窘迫综合征患者预后的价值[J].中华实用诊断与治疗杂志,2022,36(3):283-287.[41]Ma S,Zhao ML,Wang K,et al.Association of Ang-2,vWF,and EVLWI with risk of mortality in sepsis patients with concomitant ARDS:A retrospective study[J].J Formos Med Assoc,2020,119(5):950-956[42]Jeon SY,Ryu S,Oh SK,et al.Lactate dehydrogenase to albumin ratio as a prognostic factor for patients with severe infection requiring intensive care[J].Medicine(Baltimore),2021,100(41):e27538.[43]Lu Y,Guo H,Chen X,et al.Association between lactate/albumin ratio and all-cause mortality in patients with acute respiratory failure:A retrospective analysis[J].PLoS One,2021,16(8):e0255744.[44]Goyal H,Lippi G,Gjymishka A,et al.Prognostic significance of red blood cell distribution width in gastrointestinal disorders[J].World J Gastroenterol,2017,23(27):4879-4891.[45]Lippi G,Mattiuzzi C,Cervellin G.Learning more and spending less with neglected laboratory parameters:the paradigmatic case of red blood cell distribution width[J].Acta Biomed,2016,87(3):323-328.[46]李俊玉,王雅慧,刘慧珍,等.红细胞分布宽度与血小板计数比值对急诊脓毒症患者预后的预测价值[J].临床急诊杂志,2022,23(2):132-137.[47]徐海涛,黄彬,卢安阳,等.PDW/PLT、RDW/PLT与脓毒症并发急性呼吸窘迫综合征患者病情和预后的相关性分析[J].疑难病杂志,2022,21(2):145-150.[48]崔文华,宋林超,韩翡.ALB和COP及CLI在百草枯中毒合并ARDS诊断及预后的意义[J].临床急诊杂志,2020,21(7):576-580.[49]查佳安,方长太,陈园园.红细胞分布宽度联合毛细血管渗漏指数对脓毒症并发急性呼吸窘迫综合征的预后评估价值[J].临床肺科杂志,2021,26(4):530-533.
相似文献/References:
[1]何广宾,左海涛,陈永青.呼吸机相关性肺炎对急性呼吸窘迫综合征患者预后的影响[J].医学信息,2022,35(11):89.[doi:10.3969/j.issn.1006-1959.2022.11.023]
HE Guang-bin,ZUO Hai-tao,CHEN Yong-qing.Effect of Ventilator Associated Pneumonia on Prognosis of Patients with Acute Respiratory Distress Syndrome[J].Journal of Medical Information,2022,35(23):89.[doi:10.3969/j.issn.1006-1959.2022.11.023]
[2]温占兵.血管生成素-1水平变化预测脓毒症急性肺损伤的价值[J].医学信息,2018,31(13):95.[doi:10.3969/j.issn.1006-1959.2018.13.027]
WEN Zhan-bing.The Value of Angiopoietin-1 Level Change in Predicting Acute Lung Injury in Sepsis[J].Journal of Medical Information,2018,31(23):95.[doi:10.3969/j.issn.1006-1959.2018.13.027]
[3]孙继飞,张 岚.肺表面活性物质治疗足月新生儿急性呼吸窘迫综合征疗效观察[J].医学信息,2019,32(02):121.[doi:10.3969/j.issn.1006-1959.2019.02.034]
SUN Ji-fei,ZHANG Lan.Therapeutic Effect of Pulmonary Surfactant on Acute Respiratory Distress Syndrome in Full-term Neonates[J].Journal of Medical Information,2019,32(23):121.[doi:10.3969/j.issn.1006-1959.2019.02.034]
[4]徐雪峰.无创双水平气道正压通气在急性呼吸窘迫综合征患者中的应用效果分析[J].医学信息,2019,32(03):118.[doi:10.3969/j.issn.1006-1959.2019.03.037]
XU Xue-feng.Analysis of Application Effect of Non-invasive Bi-level Positive Airway Pressure Ventilation in Patients with Acute Respiratory Distress Syndrome[J].Journal of Medical Information,2019,32(23):118.[doi:10.3969/j.issn.1006-1959.2019.03.037]
[5]申 贵,彭 翔,秦光梅.抗感染督导治疗对脓毒症患者预后影响的研究[J].医学信息,2019,32(01):82.[doi:10.3969/j.issn.1006-1959.2019.01.026]
SHEN Gui,PENG Xiang,QIN Guang-mei.Study on the Effect of Anti-infective Supervision on the Prognosis of Patients with Sepsis[J].Journal of Medical Information,2019,32(23):82.[doi:10.3969/j.issn.1006-1959.2019.01.026]
[6]张恺悦,陈幼琼.乌司他丁联合血必净对烧伤后脓毒症患者凝血功能及全身炎性反应的影响研究[J].医学信息,2019,32(04):138.[doi:10.3969/j.issn.1006-1959.2019.04.044]
ZHANG Kai-yue,CHEN You-qiong.Effect of Ulinastatin Combined with Xuebijing on Coagulation Function and Systemic Inflammatory Response in Patients with Sepsis after Burn[J].Journal of Medical Information,2019,32(23):138.[doi:10.3969/j.issn.1006-1959.2019.04.044]
[7]张文旭,徐 绸.红细胞宽度对脓毒症患者病情诊断及预后评估的价值[J].医学信息,2022,35(14):71.[doi:10.3969/j.issn.1006-1959.2022.14.015]
ZHANG Wen-xu,XU Chou.The Value of Red-blood-cell Distribution Width in the Diagnosis and Prognosis of Patients with Sepsis[J].Journal of Medical Information,2022,35(23):71.[doi:10.3969/j.issn.1006-1959.2022.14.015]
[8]朱思哲,叶成林.基于生物信息学分析构建免疫相关基因脓毒症预后模型[J].医学信息,2022,35(15):1.[doi:10.3969/j.issn.1006-1959.2022.15.001]
ZHU Si-zhe,YE Cheng-lin.Identification of Immune-related Gene Prognostic Model for Sepsis Based on Bioinformatics Analysis[J].Journal of Medical Information,2022,35(23):1.[doi:10.3969/j.issn.1006-1959.2022.15.001]
[9]杨勋能.参苓白术散对脓毒症患者肠道功能的影响[J].医学信息,2019,32(16):146.[doi:10.3969/j.issn.1006-1959.2019.16.049]
YANG Xun-neng.Effect of Shenling Baizhu Powder on Intestinal Function in Patients with Sepsis[J].Journal of Medical Information,2019,32(23):146.[doi:10.3969/j.issn.1006-1959.2019.16.049]
[10]杜金洁,胡 鹏.ESKAPE病原菌感染引起脓毒症的研究[J].医学信息,2019,32(21):33.[doi:10.3969/j.issn.1006-1959.2019.21.012]
DU Jin-jie,HU Peng.Study on Sepsis Caused by ESKAPE Pathogen Infection[J].Journal of Medical Information,2019,32(23):33.[doi:10.3969/j.issn.1006-1959.2019.21.012]